Anesthetic drugs & techniques

Effect of sugammadex on processed EEG parameters in patients undergoing robot-assisted radical prostatectomy

Br J AnaesthPublished Prospective observational study

Authors' conclusion

After neuromuscular block reversal with 2 mg kg-1 sugammadex, BIS, SEF95, EMG, and beta power showed small but statistically significant increases over time, while delta power decreased.

Study context

Population
Adult men undergoing robot-assisted radical prostatectomy under sevoflurane-based GA with continuous rocuronium infusion
Participants
25 men
Exposure
After vs before sugammadex 2 mg kg-1 reversal of rocuronium NMB
Outcome
Change from baseline in BIS, SEF95, EMG and EEG band power after sugammadex
Methodological detailsBIS, EEG and electromyographic (EMG) measures captured with the BIS Vista monitor
  • BIS, EEG and EMG measures captured with the BIS Vista monitor

Main finding

As reported in the abstract

BIS at 4-6 min vs baseline
β coefficient 3.63 (95% CI 2.22–5.04); P < 0.001
SEF95 at 2-4 min vs baseline
β coefficient 0.29 (95% CI 0.05–0.52); P = 0.016
SEF95 at 4-6 min vs baseline
β coefficient 0.71 (95% CI 0.47–0.94); P < 0.001
EMG at 4-6 min vs baseline
β coefficient 1.91 (95% CI 1.00–2.81); P < 0.001
Beta power at 2-4 min vs baseline
β coefficient 93 (95% CI 1–185); P = 0.046
Beta power at 4-6 min vs baseline
β coefficient 208 (95% CI 116–300); P < 0.001
Delta power at 4-6 min vs baseline
β coefficient −526.72 (95% CI −778 to −276); P < 0.001

Observational data: associations, not effects.

Further findings

SEF95 and frequency band data adjusted for EMG

No substantial differences

Safety

Patients with clinical signs of awakening
0

Original publication

Effect of sugammadex on processed EEG parameters in patients undergoing robot-assisted radical prostatectomy. Br J Anaesth. Published 6 July 2023. doi:10.1016/j.bja.2023.06.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.